Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Net Income (2016 - 2024)

Avanos Medical (AVNS) has disclosed Net Income for 11 consecutive years, with -$300000.0 as the latest value for Q4 2024.

  • Quarterly Net Income rose 40.0% to -$300000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$300000.0 through Sep 2025, up 95.0% year-over-year, with the annual reading at -$5.8 million for FY2024, 88.82% up from the prior year.
  • Net Income hit -$300000.0 in Q4 2024 for Avanos Medical, up from -$1.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $38.5 million in Q2 2021 to a low of -$63.8 million in Q2 2023.
  • Historically, Net Income has averaged -$4.6 million across 5 years, with a median of -$400000.0 in 2023.
  • Biggest five-year swings in Net Income: skyrocketed 1383.33% in 2021 and later tumbled 928.57% in 2023.
  • Year by year, Net Income stood at -$49.0 million in 2020, then soared by 47.55% to -$25.7 million in 2021, then skyrocketed by 128.02% to $7.2 million in 2022, then crashed by 106.94% to -$500000.0 in 2023, then skyrocketed by 40.0% to -$300000.0 in 2024.
  • Business Quant data shows Net Income for AVNS at -$300000.0 in Q4 2024, -$1.6 million in Q3 2024, and -$2.5 million in Q2 2024.